Treanda and Venclexta drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Treanda (bendamustine hydrochloride) and Venclexta (venetoclax). Common drug interactions include lymphadenopathy among females and chronic lymphocytic leukaemia among males.

The phase IV clinical study analyzes what interactions people have when they take Treanda and Venclexta. It is created by eHealthMe based on reports of 15 people who take the same drugs from the FDA, and is updated regularly.

What is Treanda?

Treanda has active ingredients of bendamustine hydrochloride. It is often used in non-hodgkin's lymphoma. eHealthMe is studying from 4,411 Treanda users. Check the latest studies of Treanda.

What is Venclexta?

Venclexta has active ingredients of venetoclax. eHealthMe is studying from 31,425 Venclexta users. Check the latest studies of Venclexta.

On Jul, 29, 2026

15 people who take Treanda and Venclexta together, and have interactions are studied.

Treanda and Venclexta drug interactions.

What are the common drug interactions of Treanda and Venclexta, by gender? *:

female:

Lymphadenopathy (disease or enlargement of lymph nodes)
Neuropathy peripheral (surface nerve damage)
Pain
Palpitations (feelings or sensations that your heart is pounding or racing)
Anxiety
Blood potassium decreased
Blood urine present
Dyspnoea (difficult or laboured respiration)
Fatigue (feeling of tiredness)
Nausea (feeling of having an urge to vomit)

male:

Chronic lymphocytic leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell))
Dizziness
Dermatitis allergic (inflammation of the skin due allergic reaction)
Lymphadenopathy (disease or enlargement of lymph nodes)
Fatigue (feeling of tiredness)
Hypotension (abnormally low blood pressure)
Pneumonia
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Drug hypersensitivity
Drug ineffective

What are the common drug interactions of Treanda and Venclexta, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

Lymphadenopathy (disease or enlargement of lymph nodes)
Death
Blood urine present
Chronic lymphocytic leukaemia recurrent (repeated cancer of blood cells known as lymphocytes)
Dermatitis allergic (inflammation of the skin due allergic reaction)
Dyspnoea (difficult or laboured respiration)
Nausea (feeling of having an urge to vomit)
Platelet count decreased
Pneumonitis (inflammation of the walls of the alveoli in the lungs)
Post procedural haemorrhage (post procedural bleeding)

What are the existing conditions these people have? *

Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 13 people, 86.67%
Renal Mass (mass in kidney): 1 person, 6.67%
Renal Disorder (kidney disease): 1 person, 6.67%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 1 person, 6.67%
Neuropathy Peripheral (surface nerve damage): 1 person, 6.67%
Lymphocytic Leukaemia (a type of cancer in which the bone marrow makes too many lymphocytes): 1 person, 6.67%
Itching: 1 person, 6.67%
High Blood Pressure: 1 person, 6.67%
High Blood Cholesterol: 1 person, 6.67%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Treanda and Venclexta?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously